This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q66038317
rdf:type
wikibase:Item
schema:description
clinical trial клінічне випробування klinisch onderzoek ensayu clínicu կլինիկական փորձարկում
rdfs:label
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
skos:prefLabel
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
schema:name
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
p:P1476
wds:Q66038317-748FBFE5-7D20-4F57-8147-0018CCA2B21A
wdt:P1476
A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus Treated With a Sulfonylurea Alone
p:P582
wds:Q66038317-3E8D647F-D004-4094-84DD-3753249FB304
wdt:P582
2003-08-01T00:00:00Z
p:P31
wds:Q66038317-9CF98387-0ADD-4172-9E1B-91A1089760A8
wdt:P31
wd:Q30612
p:P580
wds:Q66038317-B52E6D1F-B299-4C14-9804-37951B5E61C5
wdt:P580
2002-02-01T00:00:00Z
p:P17
wds:Q66038317-2D9129B4-EFCA-4201-B3B5-F424D3428047
wdt:P17
wd:Q30
p:P6153
wds:Q66038317-1552B350-52FB-4C1D-B748-336CE0E5BC2C wds:Q66038317-182AC65D-FB3B-4BB8-94CD-6E4116E725D7 wds:Q66038317-232832D9-0BF2-4EF2-8486-D91463DC5513 wds:Q66038317-5B91EE7F-46EB-4D82-AAA9-AD5134943F37 wds:Q66038317-6D33DF65-5248-4A40-8FF3-D790F1B40C85 wds:Q66038317-88B1E128-DBF6-4114-80C7-9282942D6B61 wds:Q66038317-AF5291AE-F437-42FB-9A98-BD3122EC9553 wds:Q66038317-C66BD73B-8287-4FA4-B5B8-E807249B34A1 wds:Q66038317-D1A1ADE2-D589-469D-8DB1-F19B160F0E49 wds:Q66038317-D8134687-D19E-45C3-871E-9553CD23E36E wds:Q66038317-E0B32606-E544-4E01-BA05-AE73970999AD
wdt:P6153
wd:Q432637 wd:Q4796185 wd:Q30298472 wd:Q5721418 wd:Q30269592 wd:Q30269845 wd:Q30270305 wd:Q30269657 wd:Q7895818 wd:Q30279572 wd:Q71217577
p:P4844
wds:Q66038317-5F44089D-F7AA-43F7-B313-2E7C98667128
wdt:P4844
wd:Q417762
p:P2899
wds:Q66038317-C8C434EC-246A-4723-8466-070EF80FE300
wdt:P2899
16
p:P1050
wds:Q66038317-A8A7459C-3DC7-4F45-99A5-4B52F9F292D1
wdt:P1050
wd:Q12206
p:P1132
wds:Q66038317-947182EF-160E-4E78-88F0-ACB42B42DADC
wdt:P1132
377
p:P4135
wds:Q66038317-F84E0E26-04E0-4B8F-B9BF-059E0C00503B
wdt:P4135
75
p:P8363
wds:Q66038317-D85E072C-E505-48A8-9305-E991A4FBDCEC
wdt:P8363
wd:Q78089383
p:P3098
wds:Q66038317-F6929734-C975-48D3-93B3-C411C17187D8
wdt:P3098
NCT00039026
p:P6099
wds:Q66038317-5A6AD7DE-5662-444B-8F5A-975CE49F8682
wdt:P6099
wd:Q42824827